核酸標記市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、類型、方法、應用、最終用戶、地區和競爭格局分類），2021-2031年

全球核酸標記市場預計將從 2025 年的 34.1 億美元成長到 2031 年的 53.1 億美元，複合年成長率為 7.66%。

該過程涉及將可檢測的標記物（例如螢光染料、酶或放射性同位素）透過化學或酶促方式連接到DNA或RNA分子上，從而使其能夠在生物鑑定中被識別和追蹤。基因組學研究的進步和對個人化醫療日益成長的需求是推動該行業發展的主要動力，而個人化醫療需要精準的診斷工具來實現個人化的患者治療。例如，個人化醫療聯盟報告稱，FDA將在2024年核准18種新的個人化藥物，約佔所有新核准的治療性分子實體的38%。這一趨勢顯著提升了標記技術在分子診斷和藥物研發的效用。

儘管有這些正面跡象，但市場成長仍面臨一個重大障礙：先進標記試劑和檢測設備的高成本。不斷上漲的成本限制了資源匱乏的研究環境中的應用，也阻礙了發展中地區的廣泛普及。因此，儘管標記技術的應用範圍正在擴大，但資金壁壘仍阻礙著其在全球不同市場的廣泛應用。

市場促進因素

次世代定序(NGS) 工作流程的技術進步是全球核酸標記市場的主要驅動力，這需要大量精確的試劑用於樣品製備和序列檢測。向自動化實驗室工作流程和高通量篩檢的轉變，增加了酵素標記和螢光標記的消耗，而這些標記對於大規模產生可讀基因組數據至關重要。隨著定序能力的不斷發展，對能夠滿足現代儀器高通量需求的兼容型先進標記試劑盒的需求也日益成長。例如，Illumina 公司在 2024 年 2 月提交的 10-K 表格報告顯示，該公司在 2023 會計年度出貨了 352 套高通量 NovaSeq X 系統，這凸顯了高通量先進儀器的普及如何推動了對標記解決方案的需求，以高效管理海量資料集。

此外，慢性病和遺傳性疾病（尤其是癌症）在全球範圍內的日益流行，從根本上擴大了分子診斷的應用範圍。臨床檢查室越來越依賴核酸標記技術來識別與複雜病理相關的基因突變和特定生物標記物，從而實現患者分層和早期診斷。根據美國癌症協會發布的《2024年癌症事實與數據》，預計美國新增癌症病例數將首次超過200萬例，凸顯了高靈敏度檢測方法的緊迫感。為了支持應對這些健康挑戰所需的生物醫學研究，美國國立衛生研究院（NIH）已在2024年計畫預算中撥出約471億美元，為利用標記技術的研究活動提供大量資金。

市場挑戰

先進試劑和設備所需的巨額資金投入是核酸標記領域發展的主要障礙。檢測平台的高昂購置和維修成本限制了其應用，尤其是在資金緊張的學術機構和小規模受託研究機構中。當實驗室無法承擔高效能標記技術的資本支出時，他們就必須依賴過時的方法或降低實驗通量，這直接減少了從相容耗材中獲得的持續收入。

聯邦政府對科研經費的停滯不前加劇了這種經濟壓力，嚴重影響了科研機構的購買力。據美國科學促進會（AAAS）稱，美國國立衛生研究院（NIH）2024年的基本預算約為471億美元，比前一年減少約1%。經費的減少迫使各機構將資源嚴格分配到關鍵任務上，而非高成本的診斷工具，導致在對資金較為敏感的市場中，已獲批准的產品的推廣速度放緩。

市場趨勢

單細胞和空間基因組學中標記技術的應用日益廣泛，從根本上改變了市場結構，優先考慮能夠在生物組織結構內實現亞細胞解析度的探針。這一趨勢超越了批量定序，推動了先進條碼化學和螢光染料的開發，這些技術能夠在保持組織微環境完整性的同時繪製基因表現圖譜。研究人員擴大採用這些高通量標記技術來原位可視化複雜的生物相互作用，這直接促進了相容儀器和專用試劑組的銷售。為了說明這一轉變，10x Genomics公司在2024年2月公佈了2023年全年總收入為6.187億美元，比上年成長20%，這主要得益於該公司空間分析和單細胞平台的強勁應用。

同時，隨著化學修飾核酸的合成技術難度日益增加，將複雜的標記計劃外包給受託研究機構（CRO）的做法日益普遍，這代表著一項重要的結構性變革。生物製藥公司擴大將高級試劑（例如加帽mRNA和客製化標記的寡核苷酸）的生產外包給專業的CRO，以確保規模化生產並符合GMP標準。這種對外部專業知識的依賴使開發人員能夠獲得工業級的標記解決方案，同時避免內部合成過程中陡峭的學習曲線。例如，Maravai LifeSciences在2024年2月發布的報告顯示，其核酸生產部門在2023年的收入累計2.248億美元，這印證了市場對高品質外包合成和標記服務的巨大需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球核酸標記市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品分類（試劑盒、試劑）
  • 按類型（放射性同位素/放射性標記、非放射性標記）
  • 透過方法（酵素法、化學法）
  • 依應用方法（定序、微陣列、原位雜合反應、印跡技術、聚合酵素鏈鎖反應等）
  • 按最終用戶分類（製藥和生物技術公司、醫院和診斷中心、學術和研究機構、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章 北美核酸標記市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲核酸標記市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區核酸標記市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲核酸標記市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章 南美核酸標記市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球核酸標記市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Thermo Fisher Scientific
• Agilent Technologies
• Takara Bio
• New England Biolabs
• QIAGEN
• Promega
• PerkinElmer
• Zymo Research
• SeraCare Life Sciences

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Nucleic Acid Labeling Market is projected to expand from USD 3.41 Billion in 2025 to USD 5.31 Billion by 2031, reflecting a compound annual growth rate of 7.66%. This process entails the chemical or enzymatic attachment of detectable markers, such as fluorophores, enzymes, or radioisotopes, to DNA or RNA molecules to enable their identification and tracking within biological assays. The industry is largely driven by advancements in genomic research and the rising demand for personalized medicine, which necessitates precise diagnostic tools for tailoring patient treatments. For instance, the Personalized Medicine Coalition reported that in 2024, the FDA approved 18 new personalized medicines, representing approximately 38 percent of all newly approved therapeutic molecular entities, a trend that significantly enhances the utility of labeling technologies in molecular diagnostics and drug development.

Despite these positive indicators, market growth faces a substantial hurdle regarding the high cost of advanced labeling reagents and detection instruments. These elevated expenses restrict adoption within resource-constrained research environments and hinder broad accessibility in developing regions. Consequently, while the application of labeling technologies is expanding, financial barriers continue to impede widespread implementation across diverse global markets.

Market Driver

Technological advancements in Next-Generation Sequencing (NGS) workflows act as a primary catalyst for the Global Nucleic Acid Labeling Market, necessitating high volumes of precise reagents for library preparation and sequence detection. The shift toward automated laboratory workflows and high-throughput screening has intensified the consumption of enzymatic and fluorescent labels, which are crucial for generating readable genomic data at scale. As sequencing capabilities evolve, the demand for compatible, advanced labeling kits rises to meet the throughput of modern devices. For example, Illumina's February 2024 'Form 10-K' reported the shipment of 352 units of its high-throughput NovaSeq X system during the 2023 fiscal year, illustrating how the proliferation of high-capacity instrumentation fuels the need for sophisticated labeling solutions to manage vast datasets efficiently.

Additionally, the rising global prevalence of chronic diseases and genetic disorders, particularly cancer, fundamentally widens the scope of molecular diagnostics. Clinical laboratories increasingly rely on nucleic acid labeling to identify genetic mutations and specific biomarkers linked to complex pathologies, enabling patient stratification and early diagnosis. According to the American Cancer Society's 'Cancer Facts & Figures 2024', new cancer cases in the United States were projected to surpass the 2 million mark for the first time, underscoring the urgency for sensitive detection assays. To support the biomedical research necessary to tackle these health challenges, the National Institutes of Health secured a program level budget of approximately $47.1 billion in 2024, providing significant capital for research activities that utilize labeling technologies.

Market Challenge

The significant financial investment required for advanced reagents and instruments constitutes a primary barrier to the expansion of the nucleic acid labeling sector. High acquisition and maintenance costs for detection platforms limit their adoption, particularly within academic institutions and smaller contract research organizations that operate under strict fiscal constraints. When laboratories cannot justify the capital expenditure for premium labeling technologies, they are often forced to rely on older methods or reduce the scope of their experimental throughput, which directly diminishes the recurring revenue stream generated from compatible consumables.

This economic pressure is further intensified by stagnating federal support for scientific inquiry, which heavily influences the purchasing capacity of research facilities. According to the American Association for the Advancement of Science, in 2024, the National Institutes of Health received a base budget of roughly 47.1 billion dollars, marking a reduction of approximately one percent from the previous year. Such funding contractions compel institutions to allocate resources strictly toward essential operations rather than high-cost diagnostic tools, thereby slowing the uptake of labeling products in financially sensitive markets.

Market Trends

The expansion of labeling applications in Single-Cell and Spatial Genomics is fundamentally reshaping the market by prioritizing probes that deliver subcellular resolution within native tissue architectures. This trend moves beyond bulk sequencing, driving the development of advanced barcoding chemistries and fluorophores capable of mapping gene expression while preserving the tissue microenvironment. Researchers are increasingly adopting these high-plex labeling technologies to visualize complex biological interactions in situ, which directly fuels the sales of compatible instruments and proprietary reagent kits. Illustrating this shift, 10x Genomics reported in February 2024 that its total revenue for the full year 2023 reached $618.7 million, a 20 percent increase over the prior year, driven largely by the robust adoption of its spatial and single-cell platforms.

Concurrently, the growing practice of outsourcing complex labeling projects to Contract Research Organizations represents a critical structural evolution, as the synthesis of chemically modified nucleic acids becomes increasingly technically demanding. Biopharmaceutical companies are progressively delegating the manufacturing of sophisticated reagents, such as capped mRNA and custom-labeled oligonucleotides, to specialized CROs to ensure scalability and adherence to GMP standards. This reliance on external expertise allows developers to bypass the steep learning curves of in-house synthesis while accessing industrial-grade labeling solutions. Highlighting the scale of this sector, Maravai LifeSciences reported in February 2024 that its Nucleic Acid Production segment generated $224.8 million in revenue during 2023, underscoring the substantial market demand for high-quality outsourced synthesis and labeling services.

Key Market Players

• Thermo Fisher Scientific
• Agilent Technologies
• Takara Bio
• New England Biolabs
• QIAGEN
• Promega
• PerkinElmer
• Zymo Research
• SeraCare Life Sciences

Report Scope

In this report, the Global Nucleic Acid Labeling Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nucleic Acid Labeling Market, By Product

• Kits
• Reagents

Nucleic Acid Labeling Market, By Type

• Radioisotope/Radioactive Labelling
• Non-radioactive Labelling

Nucleic Acid Labeling Market, By Method

• Enzymatic
• Chemical

Nucleic Acid Labeling Market, By Application

• Sequencing
• Microarray
• In Situ Hybridization
• Blotting Techniques
• Polymerase Chain Reaction
• Others

Nucleic Acid Labeling Market, By End User

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Academic & Research Institutes
• Others

Nucleic Acid Labeling Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nucleic Acid Labeling Market.

Available Customizations:

Global Nucleic Acid Labeling Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nucleic Acid Labeling Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Kits, Reagents)
  • 5.2.2. By Type (Radioisotope/Radioactive Labelling, Non-radioactive Labelling)
  • 5.2.3. By Method (Enzymatic, Chemical)
  • 5.2.4. By Application (Sequencing, Microarray, In Situ Hybridization, Blotting Techniques, Polymerase Chain Reaction, Others)
  • 5.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, Academic & Research Institutes, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Nucleic Acid Labeling Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By Method
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Nucleic Acid Labeling Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Method
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Nucleic Acid Labeling Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Method
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Nucleic Acid Labeling Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Method
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Nucleic Acid Labeling Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By Method
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Nucleic Acid Labeling Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Method
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. France Nucleic Acid Labeling Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Method
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Nucleic Acid Labeling Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Method
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Nucleic Acid Labeling Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Method
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Nucleic Acid Labeling Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Method
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia Pacific Nucleic Acid Labeling Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By Method
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Nucleic Acid Labeling Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Method
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Nucleic Acid Labeling Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Method
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Nucleic Acid Labeling Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Method
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Nucleic Acid Labeling Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Method
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Nucleic Acid Labeling Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Method
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. Middle East & Africa Nucleic Acid Labeling Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By Method
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Nucleic Acid Labeling Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Method
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Nucleic Acid Labeling Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Method
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Nucleic Acid Labeling Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Method
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. South America Nucleic Acid Labeling Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By Method
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Nucleic Acid Labeling Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Method
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Nucleic Acid Labeling Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Method
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Nucleic Acid Labeling Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Method
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Nucleic Acid Labeling Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Agilent Technologies
• 15.3. Takara Bio
• 15.4. New England Biolabs
• 15.5. QIAGEN
• 15.6. Promega
• 15.7. PerkinElmer
• 15.8. Zymo Research
• 15.9. SeraCare Life Sciences

16. Strategic Recommendations

17. About Us & Disclaimer